(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

METI MEDI

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

METI MEDI

ST13

US500000088189799

Class

42

Filing

88189799

Registration

6077568

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

35

Latest update

06/17/2025

Trademark type

Combined

Nice classes

42

Filing date

11/12/2018

Registration date

06/16/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/16/2020

Last transaction

06/17/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

Drawing code

3

Owner type

03

Owner location

Incheon, KR

Examiner

PEETE, KYLE

Law office

M30

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consist of the word "METI", wherein the letter "M" is in black and "ETI" are in green, followed by a design of four small circles and one larger circle all of which are orange and above the word "MEDI" in which the letter "M" is in black and "EDI" are in green. The color white in the background is not part of the mark

Holders and representatives

Holders

MetiMedi Pharmaceuticals Co., Ltd.

Representatives

N. Christopher Norton ArentFox Schiff LLP

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Research and development of vaccines and medicines; Crude medicines research; Research on adult diseases; Research on cancer; Pharmaceutical products development; Research on the subject of pharmaceuticals; Pharmaceutical product evaluation; Consultancy pertaining to pharmacology; Research for medical products; Medical research; Chemistry serviceschemistry consultationresearch in the field of chemistrylaboratory research and analysis in the field of chemistry; Chemical research and analysis; Research and development of medical products for others

Publications

History of USPTO decisions and trademark events.

35 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

06/16/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/17/2022

EWOR

TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED

03/17/2022

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

03/17/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/17/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/17/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

06/16/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/31/2020

PUBO

PUBLISHED FOR OPPOSITION

03/31/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/11/2020

OTHE

CASE RETURNED TO EXAMINATION

01/27/2020

IUCN

NOTICE OF ALLOWANCE CANCELLED

01/27/2020

PCBG

PETITION TO DIRECTOR - CHANGE BASIS - GRANTED

01/27/2020

ERTI

TEAS RESPONSE TO PETITION INQUIRY LETTER

01/16/2020

PRIM

PETITION INQUIRY LETTER MAILED

01/10/2020

APET

ASSIGNED TO PETITION STAFF

01/06/2020

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

12/03/2019

TPAD

TEAS PETITION TO AMEND BASIS RECEIVED

11/15/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/08/2019

PUBO

PUBLISHED FOR OPPOSITION

10/08/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/18/2019

ALIE

ASSIGNED TO LIE

09/05/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/03/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/12/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/12/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/12/2019

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

08/08/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

08/08/2019

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

02/22/2019

GNRT

NON-FINAL ACTION E-MAILED

02/22/2019

CNRT

NON-FINAL ACTION WRITTEN

02/22/2019

DOCK

ASSIGNED TO EXAMINER

02/15/2019

MDSM

NOTICE OF DESIGN SEARCH CODE E-MAILED

11/30/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/29/2018

NWAP

NEW APPLICATION ENTERED

11/15/2018

Continuous trademark protection

Get notified about every new filing that threatens METI MEDI or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.